Ramakrishnan, Melarkode S <br/><br/>
Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin.  [electronic resource] 

 -  mAbs   
 - 41-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1942-0870 
<br/><br/><label>Standard No.: </label>10.4161/mabs.1.1.7509  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Animals<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--adverse effects<br/>Carcinoma, Squamous Cell--drug therapy<br/>Clinical Trials, Phase II as Topic<br/>Cuba<br/>ErbB Receptors--antagonists & inhibitors<br/>Glioma--drug therapy<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>India<br/>Middle Aged<br/>Nasopharyngeal Neoplasms--drug therapy